Conversion of PIP2 to PIP3 by PI3K bound to phosphorylated EGFRvIII

Stable Identifier
R-HSA-5637801
Type
Reaction [transition]
Species
Homo sapiens
Compartment
plasma membrane, cytosol, extracellular region
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Conversion of PIP2 to PIP3 by PI3K bound to phosphorylated EGFRvIII
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The kinase activity of PI3K mediates the phosphorylation of PIP2 to form PIP3. It is assumed that EGFRvIII cancer mutant induces PI3K/AKT signaling in a manner similar to wild-type EGFR. Accordingly, activation of PI3K/AKT signaling cascade has been demonstrated in cells expressing EGFRvIII (Lammering et al. 2003, Li et al. 2004)
Literature References
PubMed ID Title Journal Year
12944901 EGFRvIII-mediated radioresistance through a strong cytoprotective response

Lammering, G, Hewit, TH, Valerie, K, Contessa, JN, Amorino, GP, Dent, P, Schmidt-Ullrich, RK

Oncogene 2003
15077177 Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin

Li, B, Yuan, M, Kim, IA, Chang, CM, Bernhard, EJ, Shu, HK

Oncogene 2004
Participants
Input
Output
Participates
as an event of
Catalyst Activity

1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity of p-5Y-EGFRvIII:GRB2:GAB1:PI3K [plasma membrane]

Physical Entity
p-5Y-EGFRvIII:GRB2:GAB1:PI3K [plasma membrane] (Homo sapiens)
Activity
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity (GO:0046934)
Normal reaction
PI3K converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3) (Homo sapiens)
Functional status

Gain of function of p-5Y-EGFRvIII:GRB2:GAB1:PI3K [plasma membrane]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
Rhea
Mondo
Authored
Orlic-Milacic, M  (2011-11-04)
Reviewed
Greulich, H  (2011-11-15)
Savas, S  (2011-11-15)
Created
Orlic-Milacic, M  (2014-11-13)
Cite Us!